Recent Uptick Might Appease Editas Medicine, Inc. (NASDAQ:EDIT) Institutional Owners After Losing 35% Over the Past Year
Recent Uptick Might Appease Editas Medicine, Inc. (NASDAQ:EDIT) Institutional Owners After Losing 35% Over the Past Year
Key Insights
主要見解
- Significantly high institutional ownership implies Editas Medicine's stock price is sensitive to their trading actions
- 51% of the business is held by the top 13 shareholders
- Insiders have bought recently
- 顯著高的機構持股意味着Editas Medicine的股價對他們的交易行爲敏感。
- 前13大股東持有該業務的51%。
- 內部人士最近購買了股票。
To get a sense of who is truly in control of Editas Medicine, Inc. (NASDAQ:EDIT), it is important to understand the ownership structure of the business. With 72% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).
要了解Editas Medicine,Inc.(納斯達克:EDIT)真正的控制者是誰,重要的是要了解企業的所有權結構。機構擁有公司的最大股份,佔據了72%的股份。換句話說,該集團面臨着最大的上行潛力(或下行風險)。
Institutional investors would appreciate the 16% increase in share price last week, given their one-year losses have totalled a disappointing 35%.
機構投資者會欣賞上週股價上漲16%,因爲他們一年的虧損已累計達到令人失望的35%。
Let's take a closer look to see what the different types of shareholders can tell us about Editas Medicine.
讓我們更仔細地看一下不同類型的股東可以告訴我們關於Editas Medicine的什麼情況。
![big](https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20240717/0-03c5f876bed0be6efbb8e22976644c4e-0-27691954e7cec4f8ae101dca00619bd0.png/big)
What Does The Institutional Ownership Tell Us About Editas Medicine?
機構持股告訴我們關於Editas Medicine的什麼?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
機構通常在向自己的投資者報告時會針對一個基準進行衡量,因此一旦某隻股票被納入主要指數,他們通常會更加熱衷於該股票。我們預計大多數公司都會有一些機構在登記簿上,尤其是那些正在增長的公司。
We can see that Editas Medicine does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Editas Medicine's earnings history below. Of course, the future is what really matters.
我們可以看到Editas Medicine確實有機構投資者,他們持有公司的一部分股票。這表明一些專業投資者對公司有信譽。但是,我們不能僅僅依靠這個事實,因爲機構有時會像每個人一樣做出糟糕的投資決策。如果多個機構同時改變對某個股票的看法,你可能會看到股價快速下跌。因此,值得看一下Editas Medicine以下的盈利歷史。當然,未來才是真正重要的。
![big](https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20240717/0-03c5f876bed0be6efbb8e22976644c4e-1-96f324e470bf78460cda7a98942f3162.png/big)
Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. Hedge funds don't have many shares in Editas Medicine. The Vanguard Group, Inc. is currently the company's largest shareholder with 10% of shares outstanding. With 9.5% and 6.7% of the shares outstanding respectively, BlackRock, Inc. and Deep Track Capital, LP are the second and third largest shareholders.
投資者應該注意,機構實際擁有公司超過一半的股份,因此他們可以集體行使重要的權力。對Editas Medicine來說,對沖基金沒有太多的股份。目前The Vanguard Group, Inc.是公司最大的股東,擁有10%的流通股。BlackRock、Inc.和Deep Track Capital、LP分別擁有9.5%和6.7%的流通股,是第二大和第三大股東。
Looking at the shareholder registry, we can see that 51% of the ownership is controlled by the top 13 shareholders, meaning that no single shareholder has a majority interest in the ownership.
從股東登記冊上看,13大股東控制了51%的股權,這意味着沒有單一股東擁有這一股權的大多數利益。
Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.
研究機構持股情況是衡量和篩選股票預期表現的好方法。通過研究分析師的情緒也可以取得相同的結果。相當多的分析師涵蓋了這筆股票,所以你可以很容易地調查預測增長。
Insider Ownership Of Editas Medicine
Editas Medicine內部持股
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.
內部人員的定義在不同國家可能會稍有不同,但董事會成員始終算入其中。公司管理負責經營業務,但即使首席執行官是董事會成員,他或她也必須對董事會負責。
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
我通常認爲內部人士持股是一件好事。但是,在某些情況下,它會使其他股東更難以對董事會的決定進行問責。
Our information suggests that Editas Medicine, Inc. insiders own under 1% of the company. It seems the board members have no more than US$1.7m worth of shares in the US$456m company. Many investors in smaller companies prefer to see the board more heavily invested. You can click here to see if those insiders have been buying or selling.
我們的信息表明,Editas Medicine,Inc.內部人員擁有該公司不到1%的股份。似乎董事會成員在這家價值4,560萬美元的公司中持有價值不超過170萬美元的股票。許多小公司的投資者更喜歡看到董事會更加重視投資。你可以點擊這裏查看內部人員是否一直在買賣。
General Public Ownership
一般大衆所有權
The general public-- including retail investors -- own 21% stake in the company, and hence can't easily be ignored. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
普通公衆-包括散戶投資者-擁有該公司的 21% 的股份,因此不能輕易忽略。儘管該群體不能決定公司的方向,但它確實可以對公司的運營產生實際影響。
Private Equity Ownership
股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。
With an ownership of 6.7%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.
擁有6.7%的股份,私募股權公司有機會在創造價值的基礎上參與塑造企業策略。有時我們會看到私募股權在長期內保持不變,但一般來說,他們的投資週期更短,而且就像名字所示,不太投資於公共公司。一段時間後,他們可能會尋求出售並重新部署資本。
Next Steps:
下一步:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Take risks for example - Editas Medicine has 2 warning signs we think you should be aware of.
我覺得了解公司的實際控制者非常有趣。但爲了真正獲得洞察力,我們還需要考慮其他信息。例如風險 - Editas Medicine有2個預警信號,我們認爲您應該了解一下。
But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.
但最終,決定該業務所有者將獲得多大利益的是未來而非過去。因此,我們認爲最好查看此免費報告,以了解分析師是否預測更光明的未來。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
譯文內容由第三人軟體翻譯。